1-3 of 3
Eri Yamamoto, MD
Close
Sort by
Journal Articles

Serum Beta-2 Microglobulin Level As a Useful Prognostic Marker Of Hodgkin Lymphoma

Yuki Nakajima, MD, Naoto Tomita, MD, Reina Watanabe, MD, Yasufumi Ishiyama, MD, Eri Yamamoto, MD, Daisuke Ishibashi, MD, Megumi Itabashi, MD, Satoshi Koyama, MD, Hiroyuki Takahashi, MD, PhD, Ayumi Numata, MD, Hirotaka Takasaki, M.D., Rika Kawasaki, Hideyuki Kuwabara, MD, Masatsugu Tanaka, MD, Chizuko Hashimoto, MD, Katsumichi Fujimaki, MD, Rika Sakai, MD, Shigeki Motomura, MD, Yoshiaki Ishigatsubo, MD
Journal: Blood
Blood (2013) 122 (21): 4239.
https://doi.org/10.1182/blood.V122.21.4239.4239
Published: 2013
Journal Articles

Peripheral Blood Lymphocyte/Monocyte Ratio At 6 Months After Remission As a Predictor Of Relapse After R-CHOP Therapy In Patients With Diffuse Large B-Cell Lymphoma

Reina Watanabe, MD, Naoto Tomita, MD, Yasufumi Ishiyama, MD, Kumiko Kishimoto, MD, Eri Yamamoto, MD, Yoshimi Ishii, MD, Hiroyuki Takahashi, MD, Kazuho Miyashita, MD, Yukako Hattori, MD, Satomi Ito, MD, Takuya Miyazaki, MD, Hirotaka Takasaki, M.D., Rika Kawasaki, MD, Hideyuki Kuwabara, MD, Masatsugu Tanaka, MD, Hideyuki Koharazawa, MD, Jun Taguchi, MD, Katsumichi Fujimaki, MD, Rika Sakai, MD, Yoshiaki Ishigatsubo, MD
Journal: Blood
Blood (2013) 122 (21): 4316.
https://doi.org/10.1182/blood.V122.21.4316.4316
Published: 2013
Journal Articles

MIB-1 Labeling Index As a Prognostic Factor in Patients with Follicular Lymphoma Treated with R-CHOP Therapy

Eri Yamamoto, MD, Naoto Tomita, MD, Seiji Sakata, MD, Naoko Tsuyama, MD, Kengo Takeuchi, MD, Yuki Nakajima, MD, Kazuho Miyashita, MD, Takayoshi Tachibana, MD, Hirotaka Takasaki, MD, Masatsugu Tanaka, MD, Chizuko Hashimoto, MD, Hideyuki Koharazawa, MD, Katsumichi Fujimaki, MD, Jun Taguchi, MD, Hiroshi Harano, MD, Shigeki Motomura, MD, Yoshiaki Ishigatsubo, MD
Journal: Blood
Blood (2012) 120 (21): 1561.
https://doi.org/10.1182/blood.V120.21.1561.1561
Published: 2012